Article Details

Latham & Watkins Advises on Global Blood Therapeutics' US$5.4 Billion Sale to Pfizer

Retrieved on: 2022-08-10 15:29:39

Tags for this article:

Click the tags to see associated articles and topics

Latham & Watkins Advises on Global Blood Therapeutics' US$5.4 Billion Sale to Pfizer. View article details on hiswai:

Excerpt

(GBT) (NASDAQ: GBT) have announced the companies have entered into a definitive agreement under which Pfizer will acquire GBT, a biopharmaceutical ...

Article found on: legaldesire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up